218 related articles for article (PubMed ID: 23291092)
41. Propranolol (Hemangiol) and severe infantile haemangiomas. The drug of first choice.
Prescrire Int; 2015 Jul; 24(162):173-6. PubMed ID: 26240880
[TBL] [Abstract][Full Text] [Related]
42. Decreased eNOS protein expression in involuting and propranolol-treated hemangiomas.
Dai Y; Hou F; Buckmiller L; Fan CY; Saad A; Suen J; Richter GT
Arch Otolaryngol Head Neck Surg; 2012 Feb; 138(2):177-82. PubMed ID: 22351865
[TBL] [Abstract][Full Text] [Related]
43. Serum cytokine profiles in infants with infantile hemangiomas on oral propranolol treatment: VEGF and bFGF, potential biomarkers predicting clinical outcomes.
Park M; Jung HL; Shim YJ; Kim HS; Yoon HS; Park SK; Cheuh HW; Lee MJ; Lee JM; Park ES; Lee JH; Lim YJ; Choi YB
Pediatr Res; 2020 Nov; 88(5):749-755. PubMed ID: 32311699
[TBL] [Abstract][Full Text] [Related]
44. Local serum levels of vascular endothelial growth factor in infantile hemangioma: intriguing mechanism of endothelial growth.
Przewratil P; Sitkiewicz A; Andrzejewska E
Cytokine; 2010 Feb; 49(2):141-7. PubMed ID: 20015661
[TBL] [Abstract][Full Text] [Related]
45. Double-blind randomized pilot trial evaluating the efficacy of oral propranolol on infantile haemangiomas in infants < 4 months of age.
Léauté-Labrèze C; Dumas de la Roque E; Nacka F; Abouelfath A; Grenier N; Rebola M; Ezzedine K; Moore N
Br J Dermatol; 2013 Jul; 169(1):181-3. PubMed ID: 23301692
[No Abstract] [Full Text] [Related]
46. Use of propranolol for the treatment infantile hemangiomas in the maxillofacial region.
Sadykov RR; Podmelle F; Sadykov RA; Kasimova KR; Metellmann HR
Int J Oral Maxillofac Surg; 2013 Jul; 42(7):863-7. PubMed ID: 23618833
[TBL] [Abstract][Full Text] [Related]
47. [Infantile haemangioma: clinical and demographic characteristics, experiences in the treatment].
Csoma ZR; Dalmády S; Ábrahám R; Rózsa T; Rácz K; Kemény L
Orv Hetil; 2017 Oct; 158(39):1535-1544. PubMed ID: 28942665
[TBL] [Abstract][Full Text] [Related]
48. Evaluation of the efficacy and safety of propranolol, timolol maleate, and the combination of the two, in the treatment of superficial infantile haemangiomas.
Gong H; Xu DP; Li YX; Cheng C; Li G; Wang XK
Br J Oral Maxillofac Surg; 2015 Nov; 53(9):836-40. PubMed ID: 26427968
[TBL] [Abstract][Full Text] [Related]
49. Propranolol, a very promising treatment for ulceration in infantile hemangiomas: a study of 20 cases with matched historical controls.
Hermans DJ; van Beynum IM; Schultze Kool LJ; van de Kerkhof PC; Wijnen MH; van der Vleuten CJ
J Am Acad Dermatol; 2011 May; 64(5):833-8. PubMed ID: 21353329
[TBL] [Abstract][Full Text] [Related]
50. A retrospective analysis of systemic propranolol for the treatment of complicated infantile haemangiomas.
Schneider M; Cremer HJ; Ruef P
Acta Paediatr; 2014 Sep; 103(9):977-83. PubMed ID: 24837972
[TBL] [Abstract][Full Text] [Related]
51. Own experience in the treatment of infantile haemangiomas with propranolol - preliminary results.
Przewratil P; Sitkiewicz A; Kierzkowska B; Lewandowska M; Lewandowska M; Andrzejowska E
Med Wieku Rozwoj; 2011; 15(3 Pt 2):406-13. PubMed ID: 22253126
[TBL] [Abstract][Full Text] [Related]
52. Effects of oral propranolol on circumscribed choroidal hemangioma: a pilot study.
Tanabe H; Sahashi K; Kitano T; Tomita Y; Saito AM; Hirose H
JAMA Ophthalmol; 2013 Dec; 131(12):1617-22. PubMed ID: 24158615
[TBL] [Abstract][Full Text] [Related]
53. Evaluation of GLUT1, IGF-2, VEGF, FGF 1, and angiopoietin 2 in infantile hemangioma.
Aydin Köker S; Kömüroğlu AU; Köksoy AY; Şiraz ÜG; Tekin E; Köker A
Arch Pediatr; 2021 May; 28(4):296-300. PubMed ID: 33715934
[TBL] [Abstract][Full Text] [Related]
54. Propranolol for treatment of ulcerated infantile hemangiomas.
Saint-Jean M; Léauté-Labrèze C; Mazereeuw-Hautier J; Bodak N; Hamel-Teillac D; Kupfer-Bessaguet I; Lacour JP; Naouri M; Vabres P; Hadj-Rabia S; Nguyen JM; Stalder JF; Barbarot S;
J Am Acad Dermatol; 2011 May; 64(5):827-32. PubMed ID: 21353332
[TBL] [Abstract][Full Text] [Related]
55. Infantile haemangioma.
Léauté-Labrèze C; Harper JI; Hoeger PH
Lancet; 2017 Jul; 390(10089):85-94. PubMed ID: 28089471
[TBL] [Abstract][Full Text] [Related]
56. Propranolol, infantile haemangiomas, and serendipity: new use for an old drug.
Grech V; Scerri C
Libyan J Med; 2011 Jan; 6(1):5826. PubMed ID: 28156195
[TBL] [Abstract][Full Text] [Related]
57. Infantile haemangiomas: a challenge in paediatric dermatology.
Schwartz RA; Sidor MI; Musumeci ML; Lin RL; Micali G
J Eur Acad Dermatol Venereol; 2010 Jun; 24(6):631-8. PubMed ID: 20565561
[TBL] [Abstract][Full Text] [Related]
58. Shouldn't Propranolol Be Used to Treat All Haemangiomas?
Moodley ST; Hudson DA; Adams S; Adams KG
Aesthetic Plast Surg; 2015 Dec; 39(6):963-7. PubMed ID: 26377820
[TBL] [Abstract][Full Text] [Related]
59. Failure of propranolol in the treatment of childhood haemangiomas of the head and neck.
Goswamy J; Rothera MP; Bruce IA
J Laryngol Otol; 2011 Nov; 125(11):1164-72. PubMed ID: 21846414
[TBL] [Abstract][Full Text] [Related]
60. Treatment of infantile haemangiomas with atenolol: comparison with a historical propranolol group.
de Graaf M; Raphael MF; Breugem CC; Knol MJ; Bruijnzeel-Koomen CA; Kon M; Breur JM; Pasmans SG
J Plast Reconstr Aesthet Surg; 2013 Dec; 66(12):1732-40. PubMed ID: 24011909
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
